[Form 4] EchoStar Corporation Insider Trading Activity
Paul Gaske, EchoStar (SATS) COO, reported option and stock transactions on 09/08/2025. He was granted an employee stock option for 45,000 shares with an exercise price of $14.04 and an April 1, 2034 expiration; 23,520 options are listed as beneficially owned following the grant. The filing also shows a contemporaneous sale of 45,000 Class A shares at $80.25 and an acquisition entry of 45,000 shares at $14.04, reflecting the option grant and related transactions. After the reported transactions the filing lists 1,593 shares held directly and 750 shares held indirectly. The grant’s vesting schedule is disclosed: 40% vested immediately and the remaining 60% vests 30% per year on April 1, 2025 and April 1, 2026.
- Clear disclosure of grant terms including exercise price, expiration, and vesting schedule
- Timely filing with signature by attorney-in-fact, meeting Section 16 reporting requirements
- Vesting schedule disclosed (40% immediate, remainder vesting dates specified) which provides transparency
- Contemporaneous sale of 45,000 shares reported the same day, reducing direct holdings to 1,593 shares
- Limited remaining direct ownership (1,593 shares) may be considered small relative to the granted option size
Insights
TL;DR: Routine executive option grant with substantial immediate vesting and offsetting sale activity; neutral to stock value absent further context.
The filing documents a standard employee stock option grant of 45,000 options at a $14.04 exercise price with an extended expiration date and a defined vesting schedule that vests 40% immediately and the remainder over two specified dates. The form also reports a same-date sale of 45,000 Class A shares at $80.25 and shows the reporter holding 23,520 derivative securities after the transactions and modest direct and indirect shareholdings. For investors, the transactions disclose insider compensation and liquidity actions but do not by themselves provide information on company performance or guidance.
TL;DR: Compensation-related grant disclosed with clear vesting terms and properly reported Section 16 activity; governance disclosure appears complete.
The Form 4 includes the grant terms, exercise price, vesting schedule, and subsequent beneficial ownership counts, which are the key governance disclosures for insider awards. The immediate 40% vesting is explicitly stated and the remaining vesting dates are specified, providing transparency about potential future insider selling pressure as vesting occurs. The filing is timely and signed by an attorney-in-fact, meeting procedural requirements for Section 16 reporting.